TCIM
BSTC

TIAA CREF Investment Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

TIAA CREF Investment Management’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1.15M Sell
18,372
-13,870
-43% -$917K ﹤0.01% 2256
2018
Q4 		$1.95M Sell
32,242
-3,220
-9% -$192K ﹤0.01% 1970
2018
Q3 		$2.07M Sell
35,462
-463
-1% -$23.6K ﹤0.01% 2106
2018
Q2 		$1.61M Buy
35,925
+3,502
+11% +$151K ﹤0.01% 2285
2018
Q1 		$1.44M Buy
32,423
+7,040
+28% +$296K ﹤0.01% 2265
2017
Q4 		$1.1M Sell
25,383
-2,442
-9% -$110K ﹤0.01% 2418
2017
Q3 		$1.29M Sell
27,825
-3,365
-11% -$161K ﹤0.01% 2397
2017
Q2 		$1.54M Sell
31,190
-2,904
-9% -$152K ﹤0.01% 2338
2017
Q1 		$1.87M Sell
34,094
-572
-2% -$30.3K ﹤0.01% 2179
2016
Q4 		$1.93M Sell
34,666
-99
-0.3% -$4.76K ﹤0.01% 2212
2016
Q3 		$1.59K Sell
34,765
-10,184
-23% -$409K ﹤0.01% 2301
2016
Q2 		$1.79M Buy
44,949
+5,772
+15% +$211K ﹤0.01% 2187
2016
Q1 		$1.36M Sell
39,177
-7,440
-16% -$273K ﹤0.01% 2297
2015
Q4 		$2M Hold
46,617
– – ﹤0.01% 2152
2015
Q3 		$2.03M Buy
46,617
+18,569
+66% +$1M ﹤0.01% 2127
2015
Q2 		$1.45M Buy
28,048
+2,586
+10% +$110K ﹤0.01% 2493
2015
Q1 		$997K Sell
25,462
-3,661
-13% -$143K ﹤0.01% 2623
2014
Q4 		$1.13M Buy
29,123
+5,376
+23% +$205K ﹤0.01% 2585
2014
Q3 		$838K Buy
23,747
+4,702
+25% +$138K ﹤0.01% 2745
2014
Q2 		$513K Buy
+19,045
New +$496K ﹤0.01% 3002
2013
Q3 		– Sell
-462
Closed -$7K – 3123
2013
Q2 		$7K Buy
+462
New +$7.43K ﹤0.01% 3105

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

TIAA CREF Investment Management's BSTC Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its BioSpecifics Technologies Corp. (BSTC) stake by 43% in Q1 2019, selling an estimated $917K and leaving 18,372 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #2256.

TIAA CREF Investment Management first reported a position in BSTC in Q2 2013 and has held it in 21 quarters since. The position peaked at $2.07M in Q3 2018. 117 funds tracked by Wall St. Rank hold BSTC as of Q1 2019.

  • TIAA CREF Investment Management held 18,372 shares of BioSpecifics Technologies Corp. worth $1.15M as of Q1 2019.
  • TIAA CREF Investment Management sold 13,870 BioSpecifics Technologies Corp. shares in Q1 2019, an estimated $917K.
  • BioSpecifics Technologies Corp. made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2256 holding.
  • TIAA CREF Investment Management first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and has held it in 21 quarters since.
  • TIAA CREF Investment Management's BioSpecifics Technologies Corp. position peaked at $2.07M in Q3 2018.
  • 117 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.